Ortho Clinical Diagnostics Holdings (OCDX) executive Busky returned to the company 398,350 Stock Option
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Joseph M Busky (executive at Ortho Clinical Diagnostics Holdings plc, OCDX) reported that they returned to the company 398,350 Stock Option on May 27, 2022.
- Reporting person
- Busky Joseph M
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| May 27, 2022 | Sale back to the company (D) | Stock OptionOn 398,350 Ordinary Shares, $0.00001 par value1, 2 | -398,350 | - | - | 0 direct |
Holdings before and after
- Stock Option: 398,350 to 0 direct
Footnotes from the filing
- 1. Pursuant to the Business Combination Agreement, dated December 22, 2021 (the BCA ), by and among Coronado Topco, Inc. ( Coronado Topco ), Laguna Merger Sub, Inc., Orca Holdco, Inc., Orca Holdco 2, Inc., Quidel Corporation and the Issuer, the Issuer became a wholly owned subsidiary of Coronado Topco upon consummation of the business combinations (the Effective Time ).
- 2. At the Effective Time, each stock option, whether vested or unvested, was converted into (a) a Coronado Topco stock option on the same terms and conditions as were applicable to such stock option immediately prior to the Effective Time, except as adjusted by the BCA, (b) with respect to the portion of such stock option that is vested as of the Effective Time, the right to receive payment, in cash, equal to the cash consideration payable in respect of the Issuer's securities subject to the vested portion of such stock option and (c) with respect to the portion of such stock option that is not vested as of the Effective Time, the right to receive payment, in cash, equal to the cash consideration payable in respect of the Issuer's securities subject to the unvested portion of such stock option when it vests in accordance with its terms.
Transaction codes in this filing
- Sale back to the company:
- Code D marks a disposition back to the company under an exempt plan, as opposed to a sale in the market.
FAQ
What did Busky report in this OCDX Form 4?
Joseph M Busky (executive at Ortho Clinical Diagnostics Holdings plc, OCDX) reported that they returned to the company 398,350 Stock Option on May 27, 2022.
What does transaction code D mean on an SEC Form 4?
Code D marks a disposition back to the company under an exempt plan, as opposed to a sale in the market.
Historical context for OCDX
Earlier insider filings at OCDX
- Jun 1, 2022SEC Form 4: Schlesinger Michael A. returned 87,637 units of Ordinary Shares to the company, closing all direct ownership in the company
- Jun 1, 2022SEC Form 4 filed by Palaniappan Chockalingam
- Jun 1, 2022SEC Form 4: Yates Robert Clifton returned 323,880 units of Ordinary Shares to the company, closing all direct ownership in the company
- Jun 1, 2022SEC Form 4: Smith Christopher M returned 367,360 units of Ordinary Shares to the company, closing all direct ownership in the company
- Jun 1, 2022SEC Form 4: Dilsaver Evelyn S returned 5,200 units of Ordinary Shares to the company, closing all direct ownership in the company
Quantisnow market dataNASDAQ
OCDX
Ortho Clinical Diagnostics Holdings plc
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Listed since
- 2021
Get push alerts for OCDX
Full OCDX profile on Quantisnow Follow OCDX and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time